ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

STIM Neuronetics Inc

3.81
0.31 (8.86%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Neuronetics Inc STIM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.31 8.86% 3.81 17:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.59 3.50 3.86 3.81 3.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202415:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
01/5/202407:31GLOBENeuroStar® TMS Advances Treatment for Adolescents During..
23/4/202415:30GLOBENeuronetics to Report First Quarter 2024 Financial and..
10/4/202407:31GLOBENew Publication in Brain Stimulation Confirms Full TMS..
27/3/202415:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
25/3/202407:30GLOBENeuroStar® Advanced Therapy Receives FDA Clearance as a..
07/3/202407:22GLOBENeuronetics Announces 5-Year Exclusive Partnership with..
06/3/202415:01EDGAR2Form 8-K - Current report
05/3/202406:31EDGAR2Form 8-K - Current report
05/3/202406:30EDGAR2Form 8-K - Current report
05/3/202406:30GLOBENeuronetics Reports Record Fourth Quarter and Record Full..
01/3/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:10EDGAR2Form 144 - Report of proposed sale of securities
28/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:48EDGAR2Form 144 - Report of proposed sale of securities
28/2/202415:16EDGAR2Form 144 - Report of proposed sale of securities
27/2/202416:33EDGAR2Form 144 - Report of proposed sale of securities
26/2/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:54EDGAR2Form 144 - Report of proposed sale of securities
23/2/202415:23EDGAR2Form 144 - Report of proposed sale of securities
22/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:14EDGAR2Form 144 - Report of proposed sale of securities
20/2/202414:19EDGAR2Form 144 - Report of proposed sale of securities
20/2/202407:30GLOBENeuronetics to Report Fourth Quarter 2023 Financial and..
16/2/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:35EDGAR2Form 144 - Report of proposed sale of securities
14/2/202410:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202410:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202407:32GLOBENeuronetics Launches Latest Evolution in its TrakStar®..
09/2/202414:39EDGAR2Form 144 - Report of proposed sale of securities
07/2/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:44EDGAR2Form 144 - Report of proposed sale of securities
06/2/202415:24EDGAR2Form 144 - Report of proposed sale of securities
06/2/202407:28GLOBENeuroStar TMS Patient Access Expands Through Lucet Health..
12/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202414:33EDGAR2Form 144 - Report of proposed sale of securities
10/1/202414:56EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
10/1/202414:13EDGAR2Form 144 - Report of proposed sale of securities
08/1/202407:30EDGAR2Form 8-K - Current report
08/1/202407:30GLOBENeuronetics Reports Preliminary Fourth Quarter and Fiscal..
21/12/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202310:09EDGAR2Form 144 - Report of proposed sale of securities
20/12/202310:24EDGAR2Form 144 - Report of proposed sale of securities
19/12/202311:28EDGAR2Form 144 - Report of proposed sale of securities
18/12/202307:49GLOBENeuronetics Receives 510(k) Clearance for NeuroSite™ Coil..

Su Consulta Reciente

Delayed Upgrade Clock